Showing 2421-2430 of 2494 results for "".
- Ocuphire Pharma Raises Over $5 Million to Complete Late Phase 2 Clinical Trials for Ophthalmic Disordershttps://modernod.com/news/ocuphire-pharma-raises-over-5-million-to-complete-late-phase-2-clinical-trials-for-ophthalmic-disorders/2476760/Ocuphire Pharma announced that it has closed on over $5 million of financing. Proceeds of the offering will be used to fund multiple clinical trials of its lead drug candidate, Nyxol. Nyxol is a novel eye drop treatment for multiple front-of-the-eye disorders, including night vision distur
- Clerio Vision Acquires Manufacturer of Extreme H2O Contact Lenseshttps://modernod.com/news/clerio-vision-acquires-manufacturer-of-extreme-h2o-contact-lenses/2476732/Clerio Vision announced that it has acquired Hydrogel Vision Corporation (HVC), a manufacturer and distributor of contact lenses. Terms of the deal were not disclosed. HVC, founded in 2002, is best known for its Extreme H2O product line and its multiple differentiated offerings that
- Ocular Therapeutix Announces Christopher White as Senior Vice President, Head of Business and Corporate Developmenthttps://modernod.com/news/ocular-therapeutix-announces-christopher-white-as-senior-vice-president-head-of-business-and-corporate-development/2476725/Ocular Therapeutix announced the appointment of Christopher White as Senior Vice President, Head of Business and Corporate Development. “We are thrilled to welcome Chris to the Ocular team to oversee business and corporate development,” Antony Mattessich, President and Chief Executive Offi
- Prism Vision Group Announces Launch of New Brandhttps://modernod.com/news/prism-vision-group-announces-launch-of-new-brand/2476726/Prism Vision Group, an ophthalmology administrative services care provider organization, was officially launched. The new entity is led by Steven Madreperla, MD, PhD, a practicing ophthalmologist and one of the founding partners of NJRetina, a specialty retina practice with roots that reac
- Alcon Introduces Air Optix Plus HydraGlyde for Astigmatism Contact Lenseshttps://modernod.com/news/alcon-introduces-air-optix-plus-hydraglyde-for-astigmatism-contact-lenses/2479569/Alcon has launched Air Optix plus HydraGlyde for Astigmatism contact lenses in the United States. The newest addition to Alcon’s contact lens portfolio offers a combination of technologies that support long-lasting lens surface moisture and outstanding comfort to provide astigmatic patients a con
- Alcon Launches New Dailies Colors Contact Lenseshttps://modernod.com/news/alcon-launches-new-dailies-colors-contact-lenses/2476702/Alcon officially announced the launch of new Dailies Colors contact lenses—daily disposable contact lenses that combine eye color enhancement with the convenience of a daily wear, according to a company news release. The new line features four colors—Mystic Blue, Mystic Gray, Mystic Hazel and Mys
- NuSight Medical Announces Issuance of U.S. Patent Covering the NuLids System for Treating Dry Eye Diseasehttps://modernod.com/news/nusight-medical-announces-issuance-of-u-s-patent-covering-the-nulids-system-for-treating-dry-eye-disease/2476697/NuSight Medical, a medical device company focused on the doctor directed, at-home treatment of dry eye disease, announced that the U.S. Patent Office has issued Patent No. 10,314,763, which is directed to methods related to the treatment of dry eye disease. U.S. Patent No. 10,314,763 cover
- New Research Suggests Glaucoma Screening Could Save Three Million Years Of Blindness In Chinahttps://modernod.com/news/new-research-suggests-glaucoma-screening-could-save-three-million-years-of-blindness-in-china/2476692/New research by Orbis International, Queen’s University Belfast, and Wenzhou Medical University has found that offering glaucoma screening in China could be highly cost-effective while reducing blindness among the population. The novel findings could change
- NovaBay Pharmaceuticals Appoints Justin Hall President and CEO, and Jason Raleigh CFOhttps://modernod.com/news/novabay-pharmaceuticals-appoints-justin-hall-president-and-ceo-and-jason-raleigh-cfo/2476666/NovaBay Pharmaceuticals announced the appointments of Justin Hall as President and Chief Executive Officer, and Jason Raleigh as Chief Financial Officer. Mr. Hall has served as interim President and CEO, and Mr. Raleigh as interim CFO since March 2019. “Justin and Jason have proven their l
- Invitae Announces ID YOUR IRD Program to Expand Access to Genetic Testing for Inherited Retinal Disordershttps://modernod.com/news/invitae-announces-id-your-ird-program-to-expand-access-to-genetic-testing-for-inherited-retinal-disorders/2476648/Invitae announced the launch of “ID YOUR IRD,” an initiative with Spark Therapeutics to offer genetic testing at no charge to patients suspected by their healthcare providers of having an inherited retinal disease (IRD). “Identifying the genetic cause of an inherit